13F HOLDINGS REPORT
Essex Woodlands Management, Inc.
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001398344-23-014817
Total Value
$132.1M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TELA BIO, INC. | TELA | 4,110,709 | $41.6M | 31.51% |
| 2 | BIOVENTUS | BVS | 13,021,324 | $37.6M | 28.48% |
| 3 | EYEPOINT PHARMACEUTICALS INC | EYPT | 4,190,921 | $36.5M | 27.59% |
| 4 | REVANCE THERAPEUTICS INC | 761330109 | 457,085 | $11.6M | 8.76% |
| 5 | MEDICINOVA INC | MNOV | 1,105,941 | $2.5M | 1.93% |
| 6 | VENUS CONCEPT, INC. | VERO | 1,089,190 | $2.3M | 1.73% |